Company Kohjin Bio Co., Ltd.

Equities

177A

JP3283630006

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-24 am EDT 5-day change 1st Jan Change
1,673 JPY -3.01% Intraday chart for Kohjin Bio Co., Ltd. +8.92% 0.00%

Business Summary

Kohjin Bio Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of bacterial testing media, in vitro diagnostic drugs, cell culture media, as well as contract cell processing. The Company operates through three segments. The Tissue Culture business segment develops, manufactures, and sells tissue culture media, including serum-free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions at facilities that have obtained permission to manufacture specified cell products based on the Regenerative Medicine Safety Act.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 5,015,000 1,328,000 ( 26.48 %) 0 26.48 %
  1. Stock Market
  2. Equities
  3. 177A Stock
  4. Company Kohjin Bio Co., Ltd.